首页> 外文OA文献 >Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
【2h】

Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

机译:在意大利643例常染色体显性多囊肾病(ADPKD)患者队列中PKD1和PKD2的破译变异性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common hereditary kidney disease. We analysed PKD1 and PKD2, in a large cohort of 440 unrelated Italian patients with ADPKD and 203 relatives by direct sequencing and MLPA. Molecular and detailed phenotypic data have been collected and submitted to the PKD1/PKD2 LOVD database. This is the first large retrospective study in Italian patients, describing 701 variants, 249 (35.5%) already associated with ADPKD and 452 (64.5%) novel. According to the criteria adopted, the overall detection rate was 80% (352/440). Novel variants with uncertain significance were found in 14% of patients. Among patients with pathogenic variants, in 301 (85.5%) the disease is associated with PKD1, 196 (55.7%) truncating, 81 (23%) non truncating, 24 (6.8%) IF indels, and in 51 (14.5%) with PKD2. Our results outline the high allelic heterogeneity of variants, complicated by the presence of variants of uncertain significance as well as of multiple variants in the same subject. Classification of novel variants may be particularly cumbersome having an important impact on the genetic counselling. Our study confirms the importance to improve the assessment of variant pathogenicity for ADPKD; to this point databasing of both clinical and molecular data is crucial.
机译:常染色体显性多囊肾病(ADPKD)是最常见的遗传性肾脏疾病。通过直接测序和MLPA,我们分析了440例意大利ADPKD无关患者和203名亲属的大队列中的PKD1和PKD2。分子和详细的表型数据已被收集并提交给PKD1 / PKD2 LOVD数据库。这是在意大利患者中进行的首个大型回顾性研究,描述了701个变体,249个(35.5%)已与ADPKD相关联和452个(64.5%)新型。根据采用的标准,总检出率为80%(352/440)。在14%的患者中发现了意义不明的新型变异。在具有致病性变异的患者中,与PKD1相关的疾病为301(85.5%),其中196(55.7%)被截断,81(23%)非截断,24(6.8%)IF插入缺失和51(14.5%) PKD2。我们的研究结果概述了变异体的高等位基因异质性,并因存在同一主题中意义不明的变异体以及多个变异体而变得复杂。新变体的分类可能特别繁琐,对遗传咨询产生重要影响。我们的研究证实了改善ADPKD变异致病性评估的重要性。至此,临床和分子数据的数据库化至关重要。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号